Is TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors superior to TACE plus tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: the debate continues.

Hepatol Int

Department of Vascular Surgery, Nantong First People's Hospital, The Second Affiliated Hospital of Nantong University, 666 Shengli Road, Chongchuan District, Nantong, 226014, Jiangsu Province, China.

Published: August 2024

Download full-text PDF	Source
http://dx.doi.org/10.1007/s12072-024-10651-z	DOI Listing

Publication Analysis

tace tyrosine

tyrosine kinase

kinase inhibitors

inhibitors immune

immune checkpoint

checkpoint inhibitors

inhibitors superior

superior tace

inhibitors unresectable

unresectable hepatocellular

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!